Status: Recruiting
A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer Cachexia
This study is a prospective, real-world observational study. The objective is to evaluate the effectiveness and safety of nanocrystalline megestrol acetate in patients with cancer cachexia in real-world settings. Eligible participants were patients diagnosed with cancer cachexia who were scheduled to receive treatment with nanocrystalline megestrol acetate.
Participants needed: 495
Trial details
Phase: Phase 4Age: 18-85Biological sex: AllType: InterventionalSponsor: Changchun GeneScience Pharmaceutical Co., Ltd.Updated: Nov 21, 2025Locations: 1
Eligibility criteria
Patients with histologically and/or cytologically confirmed malignancy. [+4]
Presence of any condition affecting gastrointestinal absorption, such as dysphag... [+4]